Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1NOVO NORDISK A/S

02 3Novo Nordisk A / S

03 3Novo Nordisk A/S

04 1Novo Nordisk A/S (2)

05 3Novo Nordisk Pharma AG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

insulin degludek

Brand Name : Tresiba

Dosage Form : SOLUTION FOR INJECTION IN PRE-FILLED

Dosage Strength : 200 UNITS / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

insulin degludek

Brand Name : Tresiba

Dosage Form : SOLUTION FOR INJECTION IN CARTRIDGE

Dosage Strength : 100 UNITS / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

insulin degludek

Brand Name : Tresiba

Dosage Form : SOLUTION FOR INJECTION IN PRE-FILLED

Dosage Strength : 100 UNITS / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Insulin Degludec 300Iu 3Ml 5 Units Parenteral Use

Dosage Strength : FLEXTOUCH SC 5 pens preriemp 3 ml 100 IU/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Injection fluid, resolution

Dosage Strength : 100 E/ml

Packaging : Finish filled pen, flex touch

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Injection fluid, resolution

Dosage Strength : 100 E/ml

Packaging : Sylinderampulle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Injection fluid, resolution

Dosage Strength : 200 E/ml

Packaging : Finish filled pen, flex touch

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

degludec

Brand Name : Xultophy

Dosage Form : Injection fluid, resolution in the finished filled pen

Dosage Strength : 100 E/ml/3.6 mg/ml

Packaging : Finish filled pen

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Insulin degludecum

Brand Name : Tresiba FlexTouch

Dosage Form : Inj L?s

Dosage Strength : 100U/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Insulin degludecum

Brand Name : Tresiba FlexTouch

Dosage Form : Inj Solution

Dosage Strength : 200U/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank